Mesa Laboratories MLAB Clinical Genomics — Goodwill

Other segment segments

Similar metrics at other companies

SRT

SRTAClinical — Goodwill

$73.05M—

PSNCritical Infrastructure — Goodwill

$323.67M+6.9%

BIOClinical Diagnostics — Goodwill

$421.8M+1.3%

SEM

SEMCritical Illness Recovery Hospital — Goodwill

$1.17B+0.7%

STZConstellationwinesandspirits — Goodwill

$5.23B+2.1%

DYCommunications — Goodwill

$332.65M—

FAQ

What is Mesa Laboratories's clinical genomics — goodwill?

Mesa Laboratories (MLAB) reported clinical genomics — goodwill of $17.16M in Q2 2026.

How has Mesa Laboratories's clinical genomics — goodwill changed year-over-year?

Mesa Laboratories's clinical genomics — goodwill increased by 0.6% year-over-year, from $17.06M to $17.16M.

What is the long-term trend for Mesa Laboratories's clinical genomics — goodwill?

Over 2 years (2023 to 2026), Mesa Laboratories's clinical genomics — goodwill has grown at a -64.5% compound annual growth rate (CAGR), from $543.21M to $68.39M.

What does clinical genomics — goodwill mean?

This represents the intangible asset value recorded when the Clinical Genomics segment was acquired for a price exceeding the fair market value of its identifiable net assets. It reflects the premium paid for expected future synergies, brand reputation, and market position within the genomics industry.